As of Mar 27
| +0.04 / +1.38%|
The 1 analysts offering 12-month price forecasts for InVivo Therapeutics Holdings Corp have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +2.04% increase from the last price of 2.94.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.